Fluorouracil |
0.5 - 800 μM |
|
|
Colo320; DLD1; HT29; LoVo; SW480 |
|
increase |
Positive |
|
164 |
Nimesulide |
8 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Bafilomycin A1 |
|
|
|
pediatric B ALL cells |
|
induce |
Positive |
|
200 |
Bafilomycin A1 |
|
|
|
|
|
induce |
Positive |
|
200 |
FOX-988 |
|
|
|
|
|
increase |
Positive |
|
28 |
Sdz-51641 |
|
|
|
|
|
increase |
Positive |
|
28 |
Flufenamic Acid |
68 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Tolfenamic Acid |
50 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Mefenamic acid |
61 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Meloxicam |
153 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Sudoxicam |
223 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Piroxicam |
610 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Diflunisal |
50 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Troglitazone |
|
|
human |
hepatocytes |
cell viability assay |
induce |
Positive |
|
226 |
Diclofenac |
51 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Sulindac sulfide |
53 |
24hr |
rat |
hepatocytes |
DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis |
induce |
Positive |
AC50 (μM) |
40 |
Flufenamic Acid |
70 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
apoptolidin |
18 μM |
|
|
60 human cancer cell lines of the National Cancer Institute |
|
|
Positive |
mean |
184 |
cytovaricin |
1 μM |
|
|
60 human cancer cell lines of the National Cancer Institute |
|
|
Positive |
mean |
184 |
Oligomycin |
0.3 μM |
|
|
60 human cancer cell lines of the National Cancer Institute |
|
|
Positive |
mean |
184 |
Tolfenamic Acid |
75 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Mefenamic acid |
277 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Meloxicam |
245 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Sudoxicam |
282 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Piroxicam |
598 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Diflunisal |
79 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Diclofenac |
197 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Sulindac sulfide |
59 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Nimesulide |
21 |
24hr |
rat |
hepatocytes |
cytochrome c release (anti-cytochrome c antibody ) |
induce |
Positive |
AC50 (μM) |
40 |
Amiodarone |
100 μmol/L |
8 hours |
human |
HepG2 |
Assessment of cytochrome c release |
increase |
Positive |
observable |
4 |
benzarone |
100 μmol/L |
8 hours |
human |
HepG2 |
Assessment of cytochrome c release |
increase |
Positive |
observable |
4 |
benzbromarone |
100 μmol/L |
8 hours |
human |
HepG2 |
Assessment of cytochrome c release |
increase |
Positive |
observable |
4 |
Amiodarone |
100 μmol/L |
8 hours |
rat; Sprague–Dawley |
hepatocytes |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
4 |
benzarone |
100 μmol/L |
8 hours |
rat; Sprague–Dawley |
hepatocytes |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
4 |
benzbromarone |
100 μmol/L |
8 hours |
rat; Sprague–Dawley |
hepatocytes |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
4 |
Amiodarone |
100 μmol/L |
8 hours |
rat; Sprague–Dawley |
hepatocytes |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
4 |
benzarone |
100 μmol/L |
8 hours |
rat; Sprague–Dawley |
hepatocytes |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
4 |
benzbromarone |
100 μmol/L |
8 hours |
rat; Sprague–Dawley |
hepatocytes |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
4 |
Clotrimazole |
30 μmol/L |
24 hours |
human |
CAL27 |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
5 |
Clotrimazole |
30 μmol/L |
24 hours |
human |
SCC25 |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
5 |
Clotrimazole |
30 μmol/L |
24 hours |
human |
UM1 |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
5 |
Clotrimazole |
40 μmol/L |
24 hours |
human |
CAL27 |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
5 |
Clotrimazole |
40 μmol/L |
24 hours |
human |
SCC25 |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
5 |
Clotrimazole |
40 μmol/L |
24 hours |
human |
UM1 |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
5 |
Clotrimazole |
30 μmol/L |
24 hours |
human |
CAL27 |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
5 |
Etoposide |
|
|
|
isolated mitochondria |
|
increase |
Positive |
|
57 |
Clotrimazole |
30 μmol/L |
24 hours |
human |
SCC25 |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
5 |
Clotrimazole |
30 μmol/L |
24 hours |
human |
UM1 |
Apoptosis measurement |
increase |
Positive |
p < 0.05 |
5 |
Clotrimazole |
40 μmol/L |
24 hours |
human |
CAL27 |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
5 |
Clotrimazole |
40 μmol/L |
24 hours |
human |
SCC25 |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
5 |
Clotrimazole |
40 µM |
12 hours |
human |
CAL27 |
western blot |
increase |
Positive |
2.1875-fold decrease |
5 |
Clotrimazole |
40 µM |
12 hours |
human |
UM1 |
western blot |
increase |
Positive |
1.35-fold decrease |
5 |
Clotrimazole |
40 µM |
24 hours |
human |
CAL27 |
western blot |
increase |
Positive |
3.1818-fold decrease |
5 |
Clotrimazole |
40 µM |
24 hours |
human |
UM1 |
western blot |
increase |
Positive |
1.5-fold decrease |
5 |
Clotrimazole |
40 µM |
48 hours |
human |
CAL27 |
western blot |
increase |
Positive |
3.3333-fold decrease |
5 |
Clotrimazole |
40 µM |
48 hours |
human |
UM1 |
western blot |
increase |
Positive |
1.5882-fold decrease |
5 |
Clotrimazole |
40 µM |
12 hours |
human |
CAL27 |
western blot |
increase |
Positive |
1.3953-fold increase |
5 |
Clotrimazole |
40 µM |
24 hours |
human |
CAL27 |
western blot |
increase |
Positive |
1.3953-fold increase |
5 |
Clotrimazole |
40 µM |
24 hours |
human |
UM1 |
western blot |
increase |
Positive |
1.2623-fold increase |
5 |
Clotrimazole |
40 µM |
48 hours |
human |
CAL27 |
western blot |
increase |
Positive |
2.3256-fold increase |
5 |
Clotrimazole |
40 µM |
48 hours |
human |
UM1 |
western blot |
increase |
Positive |
1.6223-fold increase |
5 |
Clotrimazole |
150 mg/kg/day |
6 days a week for two weeks |
human |
CAL27(xenograft tumors)/mouse |
Immunohistochemistry |
increase |
Positive |
1.5-fold decrease |
5 |
Clotrimazole |
150 mg/kg/day |
6 days a week for two weeks |
human |
CAL27(xenograft tumors)/mouse |
western blot analysis |
increase |
Positive |
2.0-fold increase |
5 |
p,p'-ddt |
30 μM |
|
rat |
Sertoli cells |
|
induce |
Positive |
|
242 |
Rotenone |
0.1–0.5 nmol/mg protein |
|
|
Wistar rat brain isolated mitochondria |
|
|
Positive |
|
242 |
N-deacetyl ketoconazole |
120 μM |
0.5 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
160 μM |
0.5 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
mimosine |
0.3 mM |
|
|
U-937 leukemia cell line. |
|
|
Positive |
|
270 |
N-deacetyl ketoconazole |
120 μM |
1 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
160 μM |
1 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
80 μM |
2 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
120 μM |
2 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
160 μM |
2 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
60 μM |
4 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
80 μM |
4 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
120 μM |
4 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
160 μM |
4 hours |
rat |
hepatocytes |
Measurement of LDH activities |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
120 μM |
0.5 hours |
rat |
hepatocytes |
Measurement of LDH activities; co-treatment of 250 μM n-Octylamine |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
120 μM |
0.5 hours |
rat |
hepatocytes |
Measurement of LDH activities; co-treatment of 100 μM Methimazole |
affect |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
120 μM |
1 hours |
rat |
hepatocytes |
Measurement of LDH activities; co-treatment of 250 μM n-Octylamine |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
120 μM |
1 hours |
rat |
hepatocytes |
Measurement of LDH activities; co-treatment of 100 μM Methimazole |
affect |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
160 μM |
1 hours |
rat |
hepatocytes |
Measurement of LDH activities; co-treatment of 250 μM n-Octylamine |
increase |
Positive |
p < 0.05 |
8 |
N-deacetyl ketoconazole |
160 μM |
1 hours |
rat |
hepatocytes |
Measurement of LDH activities; co-treatment of 100 μM Methimazole |
affect |
Positive |
p < 0.05 |
8 |
Clotrimazole |
40 μmol/L |
24 hours |
human |
UM1 |
Apoptosis measurement |
increase |
Positive |
p < 0.01 |
5 |
oxaliplatin |
|
|
|
|
|
|
Positive |
|
262 |
MG-132 |
20 μM |
24 hr |
rat |
PC12 cells |
Measurement of caspase-3 activity with ApoAlert™ CPP32/Caspase-3 assay kit |
increase |
Positive |
|
289 |
MG-132 |
20 μM |
24 hr |
rat |
PC12 cells |
Measurement of cytochrome c release using a solid-phase, enzyme-linked immunosorbent assay kit for the detection of cytochrome c. |
increase |
Positive |
|
289 |
Troglitazone |
100 µM |
24hr |
|
HepG2 cells |
Apo-One homogeneous caspase 3 assay kit |
|
Positive |
|
330 |
Niclosamide |
|
|
|
|
|
induce |
Positive |
|
294 |
Dequalinium Chloride |
|
24 hr |
|
Ishikawa and Caco-2 |
WB was performed to measure the BCL-XL and released cytochrome c proteins from mitochondria; Caspase-3/7 activity was measured using the Caspase-Glo 3/7 reagent from the ApoTox-Glo Triplex Assay kit |
induce |
Positive |
|
299 |
Cisplatin |
|
24 hr |
|
Ishikawa and Caco-2 |
WB was performed to measure the BCL-XL and released cytochrome c proteins from mitochondria; Caspase-3/7 activity was measured using the Caspase-Glo 3/7 reagent from the ApoTox-Glo Triplex Assay kit |
induce |
Positive |
|
299 |
Cadmium |
100, 500 μM |
30 min |
rat |
PC12 cells |
measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe |
induce |
Positive |
|
300 |
Mercury |
10-500 μM |
30min |
rat |
PC12 cells |
measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe |
induce |
Positive |
|
300 |
Copper |
10-500 μM |
3hr |
rat |
PC12 cells |
measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe |
induce |
Positive |
|
300 |
Copper |
500 μM |
24 hr |
rat |
PC12 cells |
measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe |
induce |
Positive |
|
300 |